Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 10
Submit an article Journal homepage
589
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluation

Baricitinib: therapeutic potential for moderate to severe atopic dermatitis

Laura Calabresea A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, Italy;b Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-5238-2336View further author information
ORCID Icon,
Dalma Malvasoa A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, Italy;b Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyView further author information
,
Andrea Chiricozzia A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, Italy;b Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6739-0387View further author information
ORCID Icon,
Sara Tambonea A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, ItalyView further author information
,
Dario Francesco D’Ursoa A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, Italy;b Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyView further author information
,
Cristina Guerrierob Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyView further author information
&
Ketty Perisa A. Gemelli IRCCS, UOC Di Dermatologia, Fondazione Policlinico Universitario, Rome, Italy;b Dermatologia, Università Cattolica Del Sacro Cuore, Rome, ItalyView further author information
 show all
Pages 1089-1098 | Received 13 May 2020, Accepted 21 Jul 2020, Published online: 14 Aug 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Laura Calabrese, Andrea Chiricozzi, Clara De Simone, Barbara Fossati, Alessandra D’Amore & Ketty Peris. (2022) Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis. Expert Opinion on Drug Metabolism & Toxicology 18:5, pages 347-355.
Read now

Articles from other publishers (5)

Kamilla Koszorú, Krisztina Hajdu, Valentin Brodszky, Alex Bató, L. Hunor Gergely, Anikó Kovács, Zsuzsanna Beretzky, Miklós Sárdy, Andrea Szegedi & Fanni Rencz. (2022) Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. The European Journal of Health Economics 24:1, pages 139-152.
Crossref
Kamilla Koszorú, Krisztina Hajdu, Valentin Brodszky, Ákos Szabó, Júlia Borza, Katalin Bodai, Györgyi Pónyai, Andrea Szegedi, Miklós Sárdy & Fanni Rencz. (2022) General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic. Dermatitis 33:6S, pages S92-S103.
Crossref
Giulia Radi, Oriana Simonetti, Giulio Rizzetto, Federico Diotallevi, Elisa Molinelli & Annamaria Offidani. (2021) Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients. Healthcare 9:11, pages 1575.
Crossref
Ana Isabel Barbosa, Tiago Torres, Sofia A. Costa Lima & Salette Reis. (2021) Hydrogels: A Promising Vehicle for the Topical Management of Atopic Dermatitis. Advanced Therapeutics 4:7, pages 2100028.
Crossref
Andrea Chiricozzi, Martina Maurelli, Ketty Peris & Giampiero Girolomoni. (2020) <p>Targeting IL-4 for the Treatment of Atopic Dermatitis</p>. ImmunoTargets and Therapy Volume 9, pages 151-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.